ReviewAdvanced healthcare materials2026
3D Printing Strategies for Bioengineering Human Cornea.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bioprinting the Craniofacial Region: A New Era in Regenerative Medicine and Dentistry.Journal of functional biomaterials · 2026Review
- Porcine Corneal Models as Translational Platforms for Innovative Therapies: Current Insights and Future Directions.Journal of functional biomaterials · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Over 4.2 million people worldwide suffer from vision impairment related to corneal diseases, with the shortage of donor corneas limiting surgical interventions. The development of 3D printing provides a promising solution for corneal tissue engineering, offering precise control over dimensionality, structural organization, and cell-matrix interactions. The choice of biomaterials and printing strategies critically determines the properties of 3D-printed corneal constructs. While prior reviews have summarized general bioinks and techniques, few have addressed cornea-specific benchmarks such as transparency, curvature, and mechanical robustness. This review provides a comprehensive discussion on the current study of 3D printed cornea, with a focus on replicating the biomechanical and optical properties of native human cornea. Key limitations in current fabrication methods are outlined, and recent advancements in 3D bioprinting technologies-many of which have been successfully applied in other tissue engineering contexts-are reviewed for their potential in producing anisotropic, multilayered corneal constructs with high resolution and fidelity. 3D printing human cornea is believed to have strong potential in generating scalable and clinically relevant solutions to overcome the global donor cornea tissue shortage, and 3D printing holds a central role in their development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.